Skip to Main Content

Paper Details

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Blood Rev
5
2023
Author NameAffiliation
David P SteensmaDavid Steensma LLC
Ravindra MajetiCancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Christopher S Houriganand Blood Institute, National Institutes of Health
Stephanie HaleneYale University School of Medicine and Yale Cancer Center
Uma BorateOhio State University Comprehensive Cancer Center/ James Cancer Hospital, Ohio State University
Rafael BejarMoores Cancer Center, university of california san diego
  • 1 - 6

Datasets